HK1085133A1 - Night-time oral insulin therapy - Google Patents

Night-time oral insulin therapy

Info

Publication number
HK1085133A1
HK1085133A1 HK06105431.0A HK06105431A HK1085133A1 HK 1085133 A1 HK1085133 A1 HK 1085133A1 HK 06105431 A HK06105431 A HK 06105431A HK 1085133 A1 HK1085133 A1 HK 1085133A1
Authority
HK
Hong Kong
Prior art keywords
night
insulin therapy
oral insulin
time oral
time
Prior art date
Application number
HK06105431.0A
Other languages
English (en)
Chinese (zh)
Inventor
．戈爾德貝格
．阿維特
Original Assignee
埃米斯菲爾技術公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 埃米斯菲爾技術公司 filed Critical 埃米斯菲爾技術公司
Publication of HK1085133A1 publication Critical patent/HK1085133A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06105431.0A 2003-01-06 2006-05-09 Night-time oral insulin therapy HK1085133A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43845103P 2003-01-06 2003-01-06
US43819503P 2003-01-06 2003-01-06
US47896703P 2003-06-16 2003-06-16
PCT/US2004/000273 WO2004062587A2 (en) 2003-01-06 2004-01-06 Night-time oral insulin therapy

Publications (1)

Publication Number Publication Date
HK1085133A1 true HK1085133A1 (en) 2006-08-18

Family

ID=32719186

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06105431.0A HK1085133A1 (en) 2003-01-06 2006-05-09 Night-time oral insulin therapy

Country Status (9)

Country Link
US (1) US7384914B2 (de)
EP (1) EP1592438B1 (de)
JP (1) JP5452843B2 (de)
AU (1) AU2004204727B8 (de)
CA (1) CA2511530C (de)
ES (1) ES2465496T3 (de)
HK (1) HK1085133A1 (de)
NZ (1) NZ541058A (de)
WO (1) WO2004062587A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ534125A (en) 2002-02-20 2006-11-30 Emisphere Tech Inc A formulation comprising a GLP-1 compound and a delivery agent
EP1605895A4 (de) * 2003-03-06 2011-08-24 Emisphere Tech Inc Orale insulintherapien und protokoll
US20050203001A1 (en) 2004-03-05 2005-09-15 Emisphere Technologies, Inc. Oral insulin therapies and protocol
US20060286129A1 (en) 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
MXPA06013252A (es) * 2004-05-14 2007-02-28 Emisphere Tech Inc Compuestos y composiciones para suministrar agentes activos.
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
EP2248531A1 (de) * 2004-08-03 2010-11-10 Emisphere Technologies, Inc. Antidiabetische orale Insulinbiguanidkombination
AU2005321803B2 (en) 2004-12-29 2012-02-09 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US20090060861A1 (en) * 2005-05-25 2009-03-05 Novo Nordisk A/S Stabilized Polypeptide Formulations
JP5235661B2 (ja) * 2005-05-25 2013-07-10 ノボ・ノルデイスク・エー／エス 安定化ポリペプチド製剤
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2007133944A2 (en) 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
EP2040718B1 (de) 2006-06-28 2017-12-27 Emisphere Technologies, Inc. Galliumnitrid-formulierungen
WO2008132731A2 (en) * 2007-04-26 2008-11-06 Oramed Pharmaceuticals, Inc Methods and compositions for rectal administration of insulin
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
NZ591497A (en) 2008-08-18 2012-11-30 Entera Bio Ltd A compositions comprising a protein, a protease inhibitor and N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC) or N-(10[2-hydroxybenzoyl]amino)decanoate (SNAD) for diabetes mellitus treatment
NZ597326A (en) 2009-07-09 2013-05-31 Oshadi Drug Administration Ltd Matrix carrier compositions, methods and uses
EP2461803B1 (de) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Schnell wirkende naproxenzusammensetzung mit reduzierter wirkung auf magen und darm
IL309255A (en) 2021-07-12 2024-02-01 Zidkiyahu Simenhaus Preparations containing proteins, biologically active containing microparticle carriers from cellulose

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863896A (en) 1984-05-03 1989-09-05 Technology Unlimited, Inc. Diabetic control by combined insulin forms
RU2066551C1 (ru) * 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
US5780243A (en) * 1996-06-28 1998-07-14 Thaco Research, Ltd. Methods for the quantitative analysis of organic compounds
SE520392C2 (sv) * 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
CA2411754C (en) * 2000-06-29 2009-05-26 Emisphere Technologies, Inc. 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
US7115663B2 (en) * 2000-09-06 2006-10-03 Emisphere Technologies, Inc. Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
US20020147135A1 (en) * 2000-12-21 2002-10-10 Oliver Schnell Method and device for producing an adapted travel treatment plan for administering a medicine in the event of a long-haul journey
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US20030198666A1 (en) * 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
CA2471144C (en) * 2002-01-09 2011-06-07 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
US7137951B2 (en) * 2002-10-23 2006-11-21 Joseph Pilarski Method of food and insulin dose management for a diabetic subject
MXPA06013252A (es) 2004-05-14 2007-02-28 Emisphere Tech Inc Compuestos y composiciones para suministrar agentes activos.

Also Published As

Publication number Publication date
NZ541058A (en) 2008-06-30
EP1592438B1 (de) 2014-02-26
AU2004204727A1 (en) 2004-07-29
ES2465496T3 (es) 2014-06-05
AU2004204727B2 (en) 2006-10-19
US20060178296A1 (en) 2006-08-10
JP2006515620A (ja) 2006-06-01
AU2004204727B8 (en) 2006-11-09
EP1592438A4 (de) 2009-07-08
JP5452843B2 (ja) 2014-03-26
EP1592438A2 (de) 2005-11-09
WO2004062587A2 (en) 2004-07-29
CA2511530A1 (en) 2004-07-29
WO2004062587A3 (en) 2005-04-28
US7384914B2 (en) 2008-06-10
CA2511530C (en) 2013-07-09

Similar Documents

Publication Publication Date Title
HK1085133A1 (en) Night-time oral insulin therapy
EP1469812A4 (de) Orale insulintherapie
GB0307918D0 (en) Therapeutic use
AU2003279911A8 (en) Therapeutic formulations
GB0323258D0 (en) Therapeutic compounds
GB0219660D0 (en) Therapeutic use
IL174308A0 (en) Therapeutic formulations
EP1485077A4 (de) Arzneimittelkombinationstherapie
GB0327493D0 (en) Treatment medicament
GB0303289D0 (en) Combination therapy
PL1618130T3 (pl) Szczepionka terapeutyczna przeciw nowotworom
EP1625830A4 (de) Medizinischer manipulator
GB0325021D0 (en) Therapeutic combinations
GB0327913D0 (en) Medicament
GB0327912D0 (en) Medicament
GB0301842D0 (en) Medicament
GB0322990D0 (en) Therapeutic use
GB0314097D0 (en) Combination therapy
GB0318311D0 (en) Combination therapy
GB0316181D0 (en) Combination therapy
GB0329512D0 (en) Combination therapy
GB0314100D0 (en) Combination therapy
GB0316176D0 (en) Combination therapy
GB0307560D0 (en) Combination therapy
GB0316184D0 (en) Combination therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220106